» Journals » Future Microbiol

Future Microbiology

Future Microbiology is a peer-reviewed journal that focuses on the latest advancements and emerging trends in the field of microbiology. It covers a wide range of topics including microbial genomics, infectious diseases, antimicrobial resistance, and microbial ecology. With its interdisciplinary approach, the journal provides valuable insights into the future of microbiology and its impact on human health, agriculture, and the environment.

Details
Abbr. Future Microbiol
Start 2006
End Continuing
Frequency Eighteen no. a year, 2019-
p-ISSN 1746-0913
e-ISSN 1746-0921
Country United Kingdom
Language English
Metrics
h-index / Ranks: 3004 102
SJR / Ranks: 7342 612
CiteScore / Ranks: 5521 4.70
JIF / Ranks: 3327 3.1
Recent Articles
1.
El Meski N, El Ayoubi L, Hassani S, Bidikian N, Zakhour J, Bou Khalil J, et al.
Future Microbiol . 2025 Mar; :1-9. PMID: 40080036
Aims: Toxocariasis is a prevalent zoonotic disease worldwide caused primarily by and . Despite its prevalence, studies focusing on clinical manifestations, and laboratory findings of toxocariasis in the Middle East...
2.
Fakher S, Westenberg D
Future Microbiol . 2025 Mar; :1-17. PMID: 40079871
Bioactive glasses (BGs) are physiologically reactive surface biomaterials widely used in biomedical applications and various treatments. Borate bioactive glasses (BBGs) are third-generation BGs, and they exhibit superior biodegradable, bioactive, osteoconductive,...
3.
Du A, Sun X, Dong M, Liu Y, Chen M, Wang Y, et al.
Future Microbiol . 2025 Mar; :1-10. PMID: 40066523
Aims: This study aims to investigate how different wound microenvironmental factors (temperature, pH, and osmotic pressure) influence the autofluorescence of Staphylococcus aureus ( and its underlying molecular mechanisms, specifically focusing...
4.
Munk P, Brinch C, Aarestrup F
Future Microbiol . 2025 Mar; :1-3. PMID: 40059755
No abstract available.
5.
Manzanelli F, Clemente C, Campagno L, Beltramo D, Robledo S, Ravetti S, et al.
Future Microbiol . 2025 Mar; :1-13. PMID: 40059403
Aims: To evaluate the antibacterial and antibiofilm activities of sodium ibuprofenate (NaI) and its hypertonic variant (NaIHS) against multidrug-resistant Gram-negative bacteria (MDR-GNB) and explore their potential to inhibit β-lactamase enzymes....
6.
Toledo A, Hamamoto Filho P, Gaona Corona M, Sierra Leon D, Canela Calderon O, Zanini M, et al.
Future Microbiol . 2025 Mar; :1-7. PMID: 40035503
Extraparenchymal neurocysticercosis (EP-NC) responds poorly to anthelmintic treatment. Several factors are involved in this low responsiveness, including the host's heterogeneous immune response and the ability of the parasite to evade...
7.
Yang Q, Kang Y, Tang W, Li M, Zhao C
Future Microbiol . 2025 Feb; :1-13. PMID: 40013895
Kawasaki disease (KD) is an acute systemic immune vasculitis with predominant involvement of the medium and small arteries. It mostly affects pediatric patients, representing the most common form of pediatric...
8.
Bhowmick T, Canton R, Pea F, Quevedo J, Santerre Henriksen A, Timsit J, et al.
Future Microbiol . 2025 Feb; :1-10. PMID: 40007489
Cefepime-enmetazobactam is a β-lactam/β-lactamase inhibitor (BL/BLI) combination that has demonstrated potent activity against extended spectrum beta-lactamase (ESBL)-producing Enterobacterales, recently approved by the US FDA for the treatment of complicated urinary...
9.
Wagenlehner F, Perry C, Hooton T, Scangarella-Oman N, Millns H, Janmohamed S, et al.
Future Microbiol . 2025 Feb; :1-11. PMID: 39988828
No abstract available.
10.
Future Microbiol . 2025 Feb; :1. PMID: 39905962
No abstract available.